EDITORIAL
Accepted on 07 Oct 2024
Editorial: Innovations in Development, Translational Research and Manufacturing of CAR T cells
doi 10.3389/fimmu.2024.1504906
- 301 views
- Frontiers in Immunology
- Molecular Innate Immunity
- Research Topics
- Innovations in Development, Translational Research and Manufacturing of CAR T cells
Innovations in Development, Translational Research and Manufacturing of CAR T cells
39k
Total downloads
146k
Total views and downloads
Articles
CLINICAL TRIAL
Published on 25 Sep 2024
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma
doi 10.3389/fimmu.2024.1328368
- 3,046 views
- 4 citations
ORIGINAL RESEARCH
Published on 09 Apr 2024
A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactors
doi 10.3389/fimmu.2024.1335932
- 4,030 views
- 7 citations
METHODS
Published on 15 Feb 2024
Artificial Targets: a versatile cell-free platform to characterize CAR T cell function in vitro
doi 10.3389/fimmu.2024.1254162
- 2,386 views
- 1 citation
REVIEW
Published on 01 Feb 2024
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy
doi 10.3389/fmmed.2024.1310002
- 8,737 views
- 4 citations
BRIEF RESEARCH REPORT
Published on 22 Jan 2024
Brief research report: in-depth immunophenotyping reveals stability of CD19 CAR T-cells over time
doi 10.3389/fimmu.2024.1298598
- 2,555 views
- 4 citations
REVIEW
Published on 12 Jan 2024
Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation
doi 10.3389/fimmu.2023.1325209
- 9,313 views
- 14 citations
ORIGINAL RESEARCH
Published on 11 Jan 2024
A chimeric antigen receptor-based cellular safeguard mechanism for selective in vivo depletion of engineered T cells
doi 10.3389/fimmu.2023.1268698
- 2,094 views
- 2 citations
REVIEW
Published on 22 Dec 2023
Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
doi 10.3389/fimmu.2023.1303935
- 33,999 views
- 61 citations
REVIEW
Published on 30 Nov 2023
Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development
doi 10.3389/fimmu.2023.1260470
- 8,173 views
- 9 citations
REVIEW
Published on 27 Nov 2023
Broadening the horizon: potential applications of CAR-T cells beyond current indications
doi 10.3389/fimmu.2023.1285406
- 8,329 views
- 12 citations
REVIEW
Published on 24 Nov 2023
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations
doi 10.3389/fimmu.2023.1280826
- 3,388 views
- 2 citations
Published in
Frontiers in Immunology
Molecular Innate Immunity